Changes have been made to the guidance of type 2 diabetes management by the National Institute of Care and Excellence (NICE).
The organisation has added text on sodium–glucose cotransporter 2 (SGLT-2) inhibitors to the section on initial drug treatment. The algorithm for blood glucose lowering therapy in adults with type 2 diabetes has also been revised to allow for a footnote with links to relevant NICE guidance on SGLT-2 inhibitors.
To read more, click here.